An opioid screening instrument: Long-term evaluation of the utility of the pain medication questionnaire by Holmes et al

Pain Practice

Volumn 6, Issue 2, 2006, Pages 69-71

  Passik, Steven D ^a   Kirsh, Kenneth L ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NARCOTIC ANALGESIC AGENT;

CHRONIC PAIN; CLINICAL ASSESSMENT TOOL; DIAGNOSTIC ACCURACY; DRUG MISUSE; EDITORIAL; HUMAN; LONG TERM CARE; MINNESOTA MULTIPHASIC PERSONALITY INVENTORY; OPIATE ADDICTION; PAIN ASSESSMENT; PATIENT COMPLIANCE; PREDICTION; PRIMARY MEDICAL CARE; PSYCHOMETRY; QUESTIONNAIRE; RISK ASSESSMENT; SCREENING TEST; STRUCTURED INTERVIEW; UNSTRUCTURED INTERVIEW; VALIDATION PROCESS;

ANALGESICS, OPIOID; HUMANS; LONGITUDINAL STUDIES; OPIOID-RELATED DISORDERS; PAIN, INTRACTABLE; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SUBSTANCE ABUSE DETECTION;

EID: 33646415351     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/j.1533-2500.2006.00065.x     Document Type: Editorial

References (16)

1. Butler SF, Budman SH, Fernandez K, Jamison RN. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain. 2004;112:65-75.
2. Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: Preliminary validation of the opioid risk tool. Pain Med. 2005;6:432-442.
3. Chabal C, Erjavec MK, Jacobson L, Mariano A, Chaney E. Prescription opiate abuse in chronic pain patients: Clinical criteria, incidence, and predictors. Clin J Pain. 1997;13:150-155.
4. Coambs RB, Jarry JL. The SISAP: A new screening instrument for identifying potential opioid abusers in the management of chronic nonmalignant pain in general medical practice. Pain Res Manage. 1996;1:155-162.
5. Crowe RR, Kramer JR, Hesselbrock V, Manos G, Bocholz KK. The utility of the "Brief MAST" and the "CAGE" in identifying alcohol problems. Arch Fam Med. 1997;6:477-483.
6. Gavin DR, Ross HE, Skinner HA. Diagnostic validity of the drug abuse screening test in the assessment of DSM-III drug disorders. Br J Addict. 1989;84:301-307.
7. Hinkin CH, Castellon SA, Dickson-Fuhrman E et al. Screening for drug and alcohol abuse among older adults using a modified version of the CAGE. Am J Addict. 2001;10:319-326.
8. Leonardson GR, Kemper E, Ness FK, Koplin BA, Daniels MC, Leonardson GA. Validity and reliability of the audit and CAGE-AID in Northern Plains American Indians. Psychol Rep. 2005;97:161-166.
9. Skinner HA. The drug abuse screening test. Addict Behav. 1982;7:363-371.
10. Brown D, Fleming MF, Davis J, Bruce M, Passik SD. A new test designed to detect opioid addiction in patients receiving opioids for chronic pain. 2006; In Press.
11. Passik SD, Kirsh KL, Whitcomb LA, et al. A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Ther. 2004;26:552-561.
12. Passik SD, Kirsh KL, Whitcomb LA, et al. Monitoring outcomes during long-term opioid therapy for non-cancer pain: Results with the pain assessment and documentation tool. J Opioid Manage. 2005;1:257-266.
13. Elander J, Lusher J, Bevan D, Telfer P. Pain management and symptoms of substance dependence among patients with sickle cell disease. Soc Sci Med. 2003;57:1683-1696.
14. Elander J, Lusher J, Bevan D, Telfer P, Burton B. Understanding the causes of problematic pain management in sickle cell disease: Evidence that pseudoaddiction plays a more important role than genuine analgesic dependence. J Pain Symptom Manage. 2004;27:156-169.
15. Weissman DE, Haddox JD. Opioid pseudoaddiction: An iatrogenic syndrome. Pain. 1989;36:363-366.
16. Butcher JN, Dahlstrom WG, Graham JR, Tellegen AM, Kaemmer B. Minnesota Multiphasic Personality Inventory-2 (MMPI-2): Manual for Administration and Scoring. Minneapolis, MN: University of Minnesota Press; 1989.